Samlyn Capital, LLC Horizon Therapeutics Public LTD CO Transaction History

Samlyn Capital, LLC

$6.21 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$62.39 - $113.8 $77.5 Million - $141 Million	-1,242,001 Reduced 79.54%	319,432 $36.4 Million
Q3 2022 Nov 14, 2022	SELL	$58.92 - $84.67 $68.2 Million - $98.1 Million	-1,158,049 Reduced 42.58%	1,561,433 $96.6 Million
Q2 2022 Aug 15, 2022	BUY	$79.4 - $116.36 $21.1 Million - $30.9 Million	265,447 Added 10.82%	2,719,482 $217 Million
Q1 2022 May 16, 2022	BUY	$86.42 - $109.81 $68.2 Million - $86.6 Million	789,021 Added 47.39%	2,454,035 $258 Million
Q4 2021 Feb 14, 2022	BUY	$98.56 - $119.91 $51.4 Million - $62.6 Million	521,934 Added 45.66%	1,665,014 $179 Million
Q3 2021 Nov 15, 2021	SELL	$91.91 - $110.37 $7.08 Million - $8.5 Million	-77,042 Reduced 6.31%	1,143,080 $125 Million
Q2 2021 Aug 16, 2021	BUY	$86.24 - $95.92 $16.6 Million - $18.4 Million	191,922 Added 18.67%	1,220,122 $114 Million
Q1 2021 May 17, 2021	SELL	$71.83 - $95.48 $15.5 Million - $20.6 Million	-216,112 Reduced 17.37%	1,028,200 $94.6 Million
Q4 2020 Feb 16, 2021	BUY	$67.0 - $84.39 $35.2 Million - $44.3 Million	525,296 Added 73.06%	1,244,312 $91 Million
Q3 2020 Nov 16, 2020	SELL	$55.23 - $79.93 $46.2 Million - $66.9 Million	-836,600 Reduced 53.78%	719,016 $55.9 Million
Q2 2020 Aug 14, 2020	SELL	$30.2 - $56.98 $3.28 Million - $6.19 Million	-108,688 Reduced 6.53%	1,555,616 $86.5 Million
Q1 2020 May 15, 2020	BUY	$24.87 - $38.56 $12.1 Million - $18.8 Million	486,771 Added 41.34%	1,664,304 $49.3 Million
Q4 2019 Feb 14, 2020	BUY	$25.43 - $36.67 $3.63 Million - $5.23 Million	142,700 Added 13.79%	1,177,533 $42.6 Million
Q3 2019 Nov 14, 2019	BUY	$23.0 - $27.97 $6.24 Million - $7.59 Million	271,383 Added 35.55%	1,034,833 $28.2 Million
Q2 2019 Aug 14, 2019	BUY	$22.81 - $28.48 $17.4 Million - $21.7 Million	763,450 New	763,450 $18.4 Million

Others Institutions Holding HZNP

# of Institutions

Shares Held

2.07M

Call Options Held

Put Options Held

20K

View Full List

About Horizon Therapeutics Public Ltd Co

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

More about HZNP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Samlyn Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Samlyn Capital, LLC with notifications on news.

Account